Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9318 |
High Similarity |
NPD7266 |
Discontinued |
0.7905 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7763 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7727 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7516 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7054 |
Approved |
0.75 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7469 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7469 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7463 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7462 |
Intermediate Similarity |
NPD969 |
Suspended |
0.7453 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7422 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7378 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7289 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7229 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD37 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7125 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7122 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7107 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.6986 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6985 |
Remote Similarity |
NPD7157 |
Approved |
0.698 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6974 |
Remote Similarity |
NPD8166 |
Discontinued |
0.697 |
Remote Similarity |
NPD2684 |
Approved |
0.6966 |
Remote Similarity |
NPD7095 |
Approved |
0.6962 |
Remote Similarity |
NPD7411 |
Suspended |
0.696 |
Remote Similarity |
NPD2934 |
Approved |
0.696 |
Remote Similarity |
NPD2933 |
Approved |
0.6957 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD6799 |
Approved |
0.6944 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD5402 |
Approved |
0.6923 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD1357 |
Approved |
0.6905 |
Remote Similarity |
NPD2859 |
Approved |
0.6905 |
Remote Similarity |
NPD2860 |
Approved |
0.6905 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD3536 |
Discontinued |
0.6903 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD290 |
Approved |
0.6892 |
Remote Similarity |
NPD1933 |
Approved |
0.6879 |
Remote Similarity |
NPD3705 |
Approved |
0.6879 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD5588 |
Approved |
0.6867 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD3750 |
Approved |
0.6863 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD6653 |
Approved |
0.6842 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6828 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6818 |
Remote Similarity |
NPD968 |
Approved |
0.6813 |
Remote Similarity |
NPD1934 |
Approved |
0.6812 |
Remote Similarity |
NPD9493 |
Approved |
0.6809 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6809 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6806 |
Remote Similarity |
NPD2797 |
Approved |
0.6797 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6782 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD5763 |
Approved |
0.6776 |
Remote Similarity |
NPD5762 |
Approved |
0.6776 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD7819 |
Suspended |
0.6763 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6761 |
Remote Similarity |
NPD1535 |
Discovery |
0.6758 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6758 |
Remote Similarity |
NPD8319 |
Approved |
0.6752 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6744 |
Remote Similarity |
NPD3020 |
Approved |
0.6739 |
Remote Similarity |
NPD4198 |
Discontinued |
0.6738 |
Remote Similarity |
NPD5238 |
Clinical (unspecified phase) |
0.6738 |
Remote Similarity |
NPD5846 |
Approved |
0.6738 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6736 |
Remote Similarity |
NPD8651 |
Approved |
0.6735 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6732 |
Remote Similarity |
NPD2424 |
Discontinued |
0.673 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6726 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6714 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6713 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6712 |
Remote Similarity |
NPD5736 |
Approved |
0.6711 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6704 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6704 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6703 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6691 |
Remote Similarity |
NPD694 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.669 |
Remote Similarity |
NPD1203 |
Approved |
0.6689 |
Remote Similarity |
NPD3268 |
Approved |
0.6688 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6667 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3021 |
Approved |
0.6667 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6667 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD3022 |
Approved |
0.6667 |
Remote Similarity |
NPD7440 |
Discontinued |
0.6649 |
Remote Similarity |
NPD7585 |
Approved |
0.6647 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6645 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6642 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD6534 |
Approved |
0.6629 |
Remote Similarity |
NPD6535 |
Approved |
0.662 |
Remote Similarity |
NPD4626 |
Approved |
0.6613 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6612 |
Remote Similarity |
NPD7680 |
Approved |
0.6607 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.66 |
Remote Similarity |
NPD4140 |
Approved |
0.66 |
Remote Similarity |
NPD1240 |
Approved |
0.6595 |
Remote Similarity |
NPD7583 |
Approved |
0.6588 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6582 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6582 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6575 |
Remote Similarity |
NPD6362 |
Approved |
0.6569 |
Remote Similarity |
NPD228 |
Approved |
0.6565 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6564 |
Remote Similarity |
NPD2978 |
Approved |
0.6564 |
Remote Similarity |
NPD2977 |
Approved |
0.6564 |
Remote Similarity |
NPD7089 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD2801 |
Approved |
0.6561 |
Remote Similarity |
NPD6667 |
Approved |
0.6561 |
Remote Similarity |
NPD6666 |
Approved |
0.6557 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6552 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6552 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6552 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6552
|
Remote Similarity |
NPD6582 |
Phase 2 |